Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05645107 |
|---|---|
| Brief Title: | A Study to Evaluate Efficacy, Safety, and Pharmacokinetics of XEMBIFY® Plus Standard Medical Treatment (SMT) Compared to Placebo Plus SMT to Prevent Infections in Participants With Hypogammaglobulinemia and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia |
| First Submitted : | December 1, 2022 |
| First Submitted that Met QC Criteria : | December 1, 2022 |
| First Posted : | December 9, 2022 |
| Last Update Submitted that Met QC Criteria : | March 7, 2024 |
| Last Update Posted : | March 8, 2024 |